1. Home
  2. ARDX vs BELFA Comparison

ARDX vs BELFA Comparison

Compare ARDX & BELFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • BELFA
  • Stock Information
  • Founded
  • ARDX 2007
  • BELFA 1949
  • Country
  • ARDX United States
  • BELFA United States
  • Employees
  • ARDX N/A
  • BELFA N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • BELFA
  • Sector
  • ARDX Health Care
  • BELFA
  • Exchange
  • ARDX Nasdaq
  • BELFA Nasdaq
  • Market Cap
  • ARDX 1.4B
  • BELFA 1.1B
  • IPO Year
  • ARDX 2014
  • BELFA N/A
  • Fundamental
  • Price
  • ARDX $5.11
  • BELFA $95.60
  • Analyst Decision
  • ARDX Buy
  • BELFA
  • Analyst Count
  • ARDX 7
  • BELFA 0
  • Target Price
  • ARDX $11.75
  • BELFA N/A
  • AVG Volume (30 Days)
  • ARDX 5.8M
  • BELFA 12.1K
  • Earning Date
  • ARDX 10-31-2024
  • BELFA 10-23-2024
  • Dividend Yield
  • ARDX N/A
  • BELFA 0.26%
  • EPS Growth
  • ARDX N/A
  • BELFA N/A
  • EPS
  • ARDX N/A
  • BELFA 4.32
  • Revenue
  • ARDX $251,849,000.00
  • BELFA $524,943,000.00
  • Revenue This Year
  • ARDX $167.24
  • BELFA N/A
  • Revenue Next Year
  • ARDX $18.93
  • BELFA $3.23
  • P/E Ratio
  • ARDX N/A
  • BELFA $21.64
  • Revenue Growth
  • ARDX 87.57
  • BELFA N/A
  • 52 Week Low
  • ARDX $4.06
  • BELFA $51.00
  • 52 Week High
  • ARDX $10.13
  • BELFA $106.93
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 44.65
  • BELFA 41.24
  • Support Level
  • ARDX $4.63
  • BELFA $88.72
  • Resistance Level
  • ARDX $5.24
  • BELFA $95.14
  • Average True Range (ATR)
  • ARDX 0.42
  • BELFA 2.65
  • MACD
  • ARDX -0.00
  • BELFA -0.86
  • Stochastic Oscillator
  • ARDX 35.59
  • BELFA 29.27

About ARDX Ardelyx Inc.

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

About BELFA Bel Fuse Inc.

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

Share on Social Networks: